| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CNCR.24759 |
| P698 | PubMed publication ID | 19950125 |
| P50 | author | Suresh Senan | Q37830477 |
| Berend J Slotman | Q40690934 | ||
| P2093 | author name string | Cornelis J A Haasbeek | |
| Frank J Lagerwaard | |||
| Marilisa E Antonisse | |||
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model | Q33337271 | ||
| Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review | Q34312788 | ||
| Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer | Q34575077 | ||
| Evaluation of trends in the cost of initial cancer treatment | Q35820277 | ||
| Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study | Q36866000 | ||
| Critical review of nonsurgical treatment options for stage I non-small cell lung cancer | Q37124123 | ||
| Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy | Q37330615 | ||
| Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study | Q40010886 | ||
| Cancer in the elderly: a societal perspective from the United States | Q40021063 | ||
| Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study | Q40400572 | ||
| Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly | Q41460251 | ||
| Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. | Q43972336 | ||
| Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography | Q46763864 | ||
| Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer | Q47742916 | ||
| Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer | Q47902297 | ||
| Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer | Q48151239 | ||
| Diagnostic percutaneous transthoracic needle biopsy does not affect survival in stage I lung cancer | Q50108642 | ||
| A retrospective analysis of short and long-term survival after curative pulmonary resection for lung cancer in elderly patients. | Q51705148 | ||
| Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study. | Q51716311 | ||
| The extent of lung parenchyma resection significantly impacts long-term quality of life in patients with non-small cell lung cancer. | Q53134674 | ||
| Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer? | Q53500916 | ||
| Ageism in the management of lung cancer. | Q53658214 | ||
| Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. | Q53667358 | ||
| Cost of care for elderly cancer patients in the United States. | Q53730492 | ||
| Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer | Q57238997 | ||
| Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer | Q59587541 | ||
| Quality of Life and Survival in the 2 Years After Surgery for Non–Small-Cell Lung Cancer | Q59725428 | ||
| Lung Cancer in Elderly Patients: An Analysis of the Surveillance, Epidemiology, and End Results Database | Q61889853 | ||
| Underrepresentation of patients 65 years of age or older in cancer-treatment trials | Q73311140 | ||
| Pulmonary resection in octogenarians | Q79381746 | ||
| Outcomes in octogenarians undergoing high-risk cancer operation: a national study | Q79950181 | ||
| Population variations in the initial treatment of non-small-cell lung cancer | Q80449811 | ||
| Surgical treatment for octogenarians with lung cancer: results from a population-based series of 124 patients | Q81535900 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 406-414 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy | |
| P478 | volume | 116 |
| Q37687473 | A dosimetric and treatment efficiency evaluation of stereotactic body radiation therapy for peripheral lung cancer using flattening filter free beams |
| Q44011535 | A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer |
| Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
| Q40610439 | Accelerated hypofractionated radiation therapy (AHRT) for non-small-cell lung cancer: can we leave standard fractionation? |
| Q28083924 | Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy? |
| Q55653104 | Comparison of the progressive resolution optimizer and photon optimizer in VMAT optimization for stereotactic treatments. |
| Q38240581 | Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller |
| Q37677572 | Curative resection for lung cancer in octogenarians is justified |
| Q60908706 | Developments in Stereotactic Body Radiotherapy |
| Q35234046 | Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer |
| Q90115551 | Hypofractionated 192Ir source stereotactic ablative brachytherapy with coplanar template assistance in the primary treatment of peripheral lung cancer |
| Q41906868 | Imaging for high-precision thoracic radiotherapy |
| Q27016589 | Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer? |
| Q26864983 | Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer? |
| Q37384166 | Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy? |
| Q36235727 | LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective |
| Q96136895 | Management of The Elderly Cancer Patients Complexity: The Radiation Oncology Potential |
| Q41888159 | Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group |
| Q36476212 | Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study |
| Q47361297 | Patient-clinician communication among patients with stage I lung cancer |
| Q26851601 | Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients |
| Q35180568 | Quality of life and symptoms following stereotactic body radiotherapy in early-stage lung cancer patients |
| Q35735393 | Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer |
| Q58707448 | Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial |
| Q53062109 | Stereotactic Body Radiotherapy Versus Surgery for Medically Operable Stage I Non–Small-Cell Lung Cancer: A Markov Model–Based Decision Analysis |
| Q49310050 | Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis. |
| Q34995421 | Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study |
| Q44020055 | Stereotactic ablative radiotherapy for small lung tumors with a moderate dose. Favorable results and low toxicity |
| Q35667829 | Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies |
| Q55282076 | Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives. |
| Q64096283 | Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications |
| Q34859171 | Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity |
| Q30992150 | Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis |
| Q35143839 | Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry |
| Q49356651 | Stereotactic body radiotherapy for stage I non-small cell lung cancer |
| Q33813917 | Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancer |
| Q26781806 | Stereotactic body radiotherapy in lung cancer: an update |
| Q82084588 | Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study |
| Q35824255 | Stereotactic radiotherapy for early stage non-small cell lung cancer |
| Q35113011 | The role of stereotactic ablative radiotherapy for early-stage and oligometastatic non-small cell lung cancer: evidence for changing paradigms |
| Q36550917 | The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly |
| Q37743289 | The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? |
| Q42098921 | Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability |
| Q39015830 | Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. |
Search more.